Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
Eli Lilly and Company
IndexS&P 500 P/E27.72 EPS (ttm)5.01 Insider Own12.00% Shs Outstand958.75M Perf Week12.88%
Market Cap133.00B Forward P/E17.95 EPS next Y7.73 Insider Trans-2.86% Shs Float955.08M Perf Month4.43%
Income4.64B PEG2.40 EPS next Q1.46 Inst Own81.70% Short Float1.15% Perf Quarter5.65%
Sales22.32B P/S5.96 EPS this Y54.10% Inst Trans2.48% Short Ratio2.28 Perf Half Y24.05%
Book/sh2.87 P/B48.33 EPS next Y13.78% ROA21.60% Target Price146.14 Perf Year7.49%
Cash/sh2.54 P/C54.54 EPS next 5Y11.56% ROE295.80% 52W Range101.36 - 147.87 Perf YTD5.55%
Dividend2.96 P/FCF95.48 EPS past 5Y17.40% ROI24.60% 52W High-7.95% Beta0.24
Dividend %2.13% Quick Ratio0.90 Sales past 5Y2.60% Gross Margin78.80% 52W Low34.29% ATR8.61
Employees33625 Current Ratio1.20 Sales Q/Q8.50% Oper. Margin22.50% RSI (14)51.49 Volatility6.92% 6.85%
OptionableYes Debt/Eq5.88 EPS Q/Q28.70% Profit Margin37.30% Rel Volume0.55 Prev Close138.72
ShortableYes LT Debt/Eq5.30 EarningsApr 23 BMO Payout29.40% Avg Volume4.83M Price136.12
Recom2.40 SMA201.39% SMA50-1.08% SMA20012.49% Volume1,828,778 Change-1.87%
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Apr-01-20 11:30AM  Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year? Zacks
10:15AM  3 Drugmakers Still Worth Betting on Amid Coronavirus Woes Zacks
07:17AM  Is There An Opportunity With Eli Lilly and Company's (NYSE:LLY) 25% Undervaluation? Simply Wall St.
Mar-31-20 01:27PM  U.S. court rules for Teva in migraine patent dispute with Eli Lilly Reuters
12:26PM  Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children Zacks
08:26AM  The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions Benzinga
08:00AM  Pay a Bounty to Develop a Covid-19 Vaccine Faster Bloomberg
08:00AM  Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market Investor's Business Daily
06:30AM  Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines PR Newswire
Mar-30-20 01:30PM  You Can Gild the Lilly
06:45AM  Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis PR Newswire
Mar-29-20 11:49AM  Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic MarketWatch
Mar-27-20 03:06PM  Spiros Segalas Starts the New Year Adding 5 Stocks to Portfolio
01:35PM  Yahoo Finance Presents: Senator Kirsten Gillibrand Yahoo Finance Video
11:18AM  Bristol Myers (BMY) Clinches FDA Nod for MS Drug Zeposia Zacks
08:14AM  Drugmaker Vertex to delay new clinical studies due to coronavirus Reuters
Mar-24-20 01:08PM  Agios' IND for PKR Activator AG-946 Gets FDA Clearance Zacks
10:02AM  Lilly Halts Enrollment, Biotechs Focus to Find Coronavirus Cure Zacks
08:59AM  What Is the Nifty 50? Investopedia
08:00AM  Updates from Lilly about insulin supply and affordability PR Newswire
Mar-23-20 03:36PM  Coronavirus pandemic leads big drugmakers to hit pause on clinical trials Reuters
10:30AM  Eli Lilly names new communications exec American City Business Journals
10:11AM  Lilly to halt enrollment in clinical trials as a result of COVID-19 MarketWatch
09:29AM  Lilly Gets CRL for Jardiance in Type I Diabetes Indication Zacks
09:15AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck Zacks
08:34AM  Eli Lilly to delay new studies as coronavirus puts strain on hospitals Reuters
06:43AM  Eli Lilly to delay new studies due to coronavirus outbreak Reuters
06:30AM  Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic PR Newswire
Mar-22-20 04:45PM  Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers PR Newswire
Mar-21-20 11:19AM  Market Experts Say the Coronavirus Selloff Is Worse Than Anything Weve Seen Since 1929. Heres How Bad It Could Get.
Mar-20-20 04:30PM  US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes PR Newswire -8.03%
10:52AM  Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates Zacks
10:30AM  Kathryn Beiser to join Lilly as Vice President, Global Communications PR Newswire
Mar-19-20 07:00AM  Two generic drugs being tested in U.S. in race to find coronavirus treatments Reuters -6.99%
Mar-18-20 03:54PM  Eli Lilly partners with Indiana to speed up coronavirus testing Reuters
02:45PM  Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories PR Newswire
11:45AM  Why Eli Lilly (LLY) is a Great Dividend Stock Right Now Zacks
06:01AM  Biotech pushes blood disorder cell therapy to clinic after $80M round American City Business Journals
Mar-17-20 11:33AM  Lilly's Olumiant Gets Breakthrough Therapy Tag for Hair Loss Zacks +10.68%
Mar-16-20 10:46AM  4 Big Drug/Biotech Stocks Up in Coronavirus-Hit Economy Zacks -7.17%
08:34AM  I Have More Hope for Eli Lilly's Research Partnership Than Its Charts
06:45AM  Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata PR Newswire
Mar-14-20 08:00AM  Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep These Five Under Observation Investor's Business Daily
Mar-13-20 11:36AM  Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates Zacks +10.59%
11:01AM  Coronavirus Drug Development Efforts Pick Up Amid Sell-Off Zacks
10:53AM  The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals Benzinga
Mar-12-20 08:40PM  Is Eli Lilly and Company (LLY) A Good Stock To Buy? Insider Monkey -10.00%
06:17PM  Eli Lilly, AbCellera Biologics to co-develop coronavirus therapies Reuters
06:11PM  AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19 PR Newswire
08:18AM  Dow Jones Futures Tumble As Trump Bans Travel From Europe; Coronavirus Stock Market Correction Is A Bear Investor's Business Daily
08:00AM  US FDA grants Fast Track designation to Jardiance® for the treatment of chronic kidney disease PR Newswire
Mar-11-20 02:31PM  Dow Jones Makes Bear Market Correction On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020? Investor's Business Daily
02:20PM  Aduro's (ADRO) Earnings & Revenues Miss Estimates in Q4 Zacks
12:36PM  Lilly to Participate in New Model Designed to Make Insulins More Affordable for Seniors in Medicare Part D PR Newswire
11:22AM  Pharma M&A Has Slowed to a Crawl
09:54AM  Eli Lilly Gets Analyst Praise Investor's Business Daily Video
08:45AM  US govt aims at high insulin prices with plan for $35 copay in Medicare Reuters
Mar-10-20 12:30AM  More choice means higher prices for American diabetics Financial Times
Mar-09-20 03:19PM  Eli Lilly and 2 More Drug Stocks That Could Ride Out the Coronavirus Crisis, According to J.P. Morgan
02:48PM  Two Companies Are Making Progress on Coronavirus Treatments. The Stocks Arent Responding.
12:10PM  Lilly to Participate in Barclays Global Healthcare Conference PR Newswire
Mar-06-20 10:18AM  Pharma Stock Roundup: Trump, Pharma Executives Meeting on Coronavirus, FDA Updates Zacks
Mar-05-20 02:56PM  Top Stock Reports for Walmart, Pfizer & Charter Communications Zacks
Mar-04-20 09:44AM  Lilly Expects No Drug Supply Shortages Due to Coronavirus Zacks +7.73%
Mar-03-20 08:48AM  Eli Lilly Says Coronavirus Won't Hurt Its Medicine Supply
07:23AM  The Zacks Analyst Blog Highlights: Eli Lilly, Union Pacific, Lockheed Martin, Bayer and Prologis Zacks
07:10AM  Eli Lilly says it does not expect any shortages of medicines, including insulin, due to coronavirus MarketWatch
07:05AM  Eli Lilly does not expect drug shortages due to coronavirus Reuters
07:00AM  Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company's Medicines PR Newswire
Mar-02-20 02:14PM  Top Stock Reports for Eli Lilly, Union Pacific & Lockheed Zacks +5.32%
11:45AM  This is Why Eli Lilly (LLY) is a Great Dividend Stock Zacks
06:45AM  U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis PR Newswire
Feb-29-20 11:31AM  Lilly (LLY) Down 11.6% Since Last Earnings Report: Can It Rebound? Zacks
Feb-28-20 09:55AM  Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit Zacks
Feb-27-20 06:11PM  Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches Reuters
Feb-26-20 07:27PM  FDA Advisory Committee Votes in Favor of Lilly's CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer PR Newswire
Feb-21-20 08:35PM  FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patients Reuters
07:50PM  Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease PR Newswire
07:37PM  U.S. FDA approves Lundbeck's migraine prevention therapy Reuters
06:16PM  Mairs and Power: Top 4th-Quarter Trades
03:45PM  Lilly to Participate in Cowen Health Care Conference PR Newswire
03:10PM  Lilly To Participate in SVB Leerink Global Healthcare Conference PR Newswire
11:10AM  Pharmaceutical companies develop system to better track counterfeit drugs Reuters
Feb-20-20 05:10PM  Oscar Health unveils program for lower drug prices, including insulin Yahoo Finance
08:55AM  Lilly Completes Acquisition of Dermira PR Newswire
Feb-14-20 11:45AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead
Feb-11-20 10:33AM  These Pharma Giants Took A Hit On Two More Alzheimer's Failures Investor's Business Daily
09:12AM  Lilly Reports Disappointing Data on Alzheimer's Candidate Zacks
Feb-10-20 04:19PM  US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return Reuters
02:27PM  US STOCKS-Nasdaq hits new high as investors look beyond coronavirus Reuters
01:16PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
12:22PM  Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint Benzinga
12:05PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
10:32AM  US STOCKS-Wall St steady as investors weigh coronavirus risks Reuters
09:55AM  Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease Reuters
09:32AM  Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial
09:19AM  Lilly and Biogen Stocks Get Hit as Another Alzheimers Treatment Fails a Trial
08:58AM  US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks Reuters
08:01AM  Lilly's stock falls on failed Alzheimer's study MarketWatch
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; and Avidity Biosciences, Inc., as well as AbCellera Biologics Inc. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerMar 31Sale140.0738,9625,457,474113,271,342Apr 01 01:47 PM
LILLY ENDOWMENT INC10% OwnerMar 30Sale139.11210,00029,213,559113,310,304Mar 31 04:03 PM
Fry Stephen FSVP, HR & DiversityMar 30Sale134.3014,6571,968,434107,415Mar 31 11:50 AM
Norton JohnaSenior VP, Global QualityMar 16Sale131.004,727619,23717,674Mar 18 10:44 AM
O'Neill MylesSVP & Pres., Mfg. OperationsMar 04Sale140.1525,0003,503,7508,469Mar 06 10:46 AM
Zakrowski Donald AChief Accounting OfficerMar 02Sale128.003,700473,6004,740Mar 03 03:27 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.00970162Feb 18 02:57 PM
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale138.92205,00028,478,495113,720,304Jan 14 01:37 PM
LILLY ENDOWMENT INC10% OwnerJan 10Sale138.00210,00028,979,013113,925,304Jan 13 11:00 AM
LILLY ENDOWMENT INC10% OwnerJan 09Sale135.79220,00029,874,729114,135,304Jan 10 01:45 PM
LILLY ENDOWMENT INC10% OwnerJan 08Sale133.32172,65023,018,105114,355,304Jan 09 02:04 PM
LILLY ENDOWMENT INC10% OwnerJan 07Sale132.9032,6454,338,579114,527,954Jan 08 11:33 AM
LILLY ENDOWMENT INC10% OwnerDec 20Sale132.9019,7052,618,812114,560,599Dec 23 09:48 AM
LILLY ENDOWMENT INC10% OwnerDec 18Sale129.29220,00028,443,848114,580,304Dec 19 02:36 PM
LILLY ENDOWMENT INC10% OwnerDec 17Sale125.69215,00027,023,552114,800,304Dec 18 11:31 AM
LILLY ENDOWMENT INC10% OwnerDec 09Sale119.7010,9621,312,151115,015,304Dec 10 11:49 AM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 06Sale120.0025,0003,000,00033,414Dec 10 11:56 AM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 06Sale120.004,500540,00029,306Dec 09 04:37 PM
LILLY ENDOWMENT INC10% OwnerDec 06Sale120.15194,03823,313,498115,026,266Dec 09 09:51 AM
LILLY ENDOWMENT INC10% OwnerDec 04Sale118.52210,00024,890,040115,220,304Dec 05 01:31 PM
LILLY ENDOWMENT INC10% OwnerNov 27Sale117.5148,9535,752,257115,430,304Dec 02 01:40 PM
LILLY ENDOWMENT INC10% OwnerNov 26Sale117.8156,7296,683,470115,479,257Nov 27 10:40 AM
LILLY ENDOWMENT INC10% OwnerNov 25Sale117.60109,31812,855,797115,535,986Nov 26 11:19 AM
LILLY ENDOWMENT INC10% OwnerNov 22Sale116.25251,73629,263,596115,645,304Nov 25 04:29 PM
LILLY ENDOWMENT INC10% OwnerNov 21Sale115.14108,26412,465,506115,897,040Nov 22 10:56 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.06205,00023,586,776116,005,304Nov 20 10:17 AM
LILLY ENDOWMENT INC10% OwnerNov 18Sale114.0010,5981,208,172116,210,304Nov 19 12:00 PM
LILLY ENDOWMENT INC10% OwnerNov 12Sale114.007,981909,841116,220,902Nov 13 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 11Sale114.0710011,407116,228,883Nov 12 01:12 PM
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM